VNDA
Vanda Pharmaceuticals Inc
4.50$
-1.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +101.4% | +1.4% | +167.1% | -48.4% | +352.0% | -5.6% | -14.3% | -25.8% | +5.8% | +19.8% | +24.1% | -1.3% | -2.4% | +61.7% | +45.7% | +10.3% | +11.3% | +6.8% | +2.2% | +1.2% | -25.5% | |
| – | +102.9% | +1.3% | +157.1% | -45.1% | +346.0% | -5.0% | -24.1% | -17.9% | +7.7% | +4.5% | +17.5% | +4.6% | -2.5% | +76.1% | +18.4% | +15.5% | +16.9% | +8.6% | -16.6% | +1.4% | -20.9% | |
| – | +29.2% | +47.2% | +35.6% | -6.8% | +425.3% | -79.3% | +106.6% | +1.0% | -27.0% | -6.0% | -16.5% | -20.5% | -16.8% | +81.4% | -26.1% | +35.4% | -14.7% | +159.3% | +0.6% | -24.7% | -17.1% | |
| – | +91.6% | +2.3% | +167.2% | -45.5% | +341.9% | -3.5% | -24.8% | -19.1% | +8.3% | -0.4% | +10.3% | -1.3% | +1.5% | +79.5% | +21.3% | +17.8% | +17.7% | +7.9% | -16.8% | -3.5% | -29.6% | |
| – | – | – | -95.0% | – | – | -84.6% | +239.3% | -32.6% | +73.9% | +79.9% | +346.9% | +24.1% | -13.2% | +63.5% | -8.4% | +13.9% | +8.1% | +3.2% | +1.9% | +37.9% | +15.9% | |
| – | – | – | -22.3% | – | – | -31.7% | -100.0% | – | +829.8% | +875.5% | -75.0% | -39.8% | +7.8% | +18.3% | +14.7% | +12.3% | -19.9% | +16.5% | +13.7% | +27.2% | +7.3% | |
| – | -11.3% | +67.4% | -27.6% | +30.6% | -25.1% | -28.9% | +2.9% | +143.6% | -6.4% | +10.9% | +87.5% | +9.7% | +5.8% | -16.8% | -12.5% | +7.0% | +199.4% | -79.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -13.6% | -15.7% | -18.6% | -22.9% | +430.6% | +45.0% | -28.2% | -6.3% | -5.9% | -6.1% | -6.4% | -6.9% | -7.5% | +553.8% | -6.0% | +2.6% | |
| – | +181.3% | +86.8% | +38.2% | -70.2% | +5,079.0% | -13.5% | -15.0% | -15.8% | -21.0% | -89.0% | +635.0% | -1.2% | -6.3% | -23.4% | +28.4% | +10.1% | +10.8% | +20.5% | -3.3% | +13.6% | +37.5% | |
| – | +212.0% | +79.8% | +40.3% | -73.3% | +824.5% | -1.6% | +1.9% | +2.0% | +1.8% | -76.3% | +559.1% | -1.9% | +39.8% | -24.7% | +12.2% | +10.8% | +12.9% | +22.9% | -4.1% | +14.0% | +45.2% | |
| – | -32.5% | +91,117.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.4% | +9.2% | +0.7% | +3.0% | +78.1% | +30.1% | |
| – | +213.8% | +23.4% | +7.4% | -82.9% | +373.1% | -73.3% | +53.7% | -71.2% | +130.3% | +26.3% | +336.4% | -6.1% | +494.4% | -82.1% | +62.2% | -82.2% | -11.8% | +1,271.9% | -43.7% | -51.0% | +41.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | |
| – | +92.3% | -12.7% | +212.9% | -45.0% | -50.0% | +63.8% | -11.3% | -70.4% | +345.5% | +264.5% | -17.3% | -1.3% | +0.0% | +109.6% | +49.2% | +10.3% | +11.4% | +4.4% | +3.4% | -1.2% | -39.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -96.6% | +64.7% | +1.1% | +1.4% | +5.6% | -1.5% | +0.4% | +7.5% | +20.9% | +15.2% | +2.8% | +3.0% | +18.6% | +3.4% | +0.6% | +3.1% | +0.1% | +1.0% | +1.0% | +1.3% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.